Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › BIOA

SPHERA FUNDS MANAGEMENT LTD. position in BIOA

BIOAGE LABS INC · Health Care

SPHERA FUNDS MANAGEMENT LTD. reported holding 213,671 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$5.2M, representing 0.73% of its reported portfolio and ranking #46 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed BIOA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)213.67K sh
Reported value held$5.24M
Portfolio Weight0.73%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SPHERA FUNDS MANAGEMENT LTD.'s BIOA position evolved

SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in BIOA in Q4 2025 at 243,035 shares (US$3.2M). The position peaked in Q2 2026 at 213,671 shares, worth US$5.2M. Across 3 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 213,671 shares valued at US$5.2M — an increase of 127,153 shares quarter over quarter.. Notable position changes include a 64% trim in Q1 2026 (shares rose 40% over the following quarter), a 147% increase in Q2 2026 (shares fell 71% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 243.03K $3.22M New
Q1 2026 86.52K $1.51M Reduce
Q2 2026 213.67K $5.24M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has SPHERA FUNDS MANAGEMENT LTD. held BIOA?

SPHERA FUNDS MANAGEMENT LTD. has disclosed BIOA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SPHERA FUNDS MANAGEMENT LTD.'s current position in BIOA?

As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 213.67K shares of BIOA (BIOAGE LABS INC), valued at $5.24M, representing 0.73% of its reported portfolio and ranking #46.

Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling BIOA?

In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. increased its position in BIOA. The position peaked in Q2 2026 at 213.67K shares.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.